BioCentury | Mar 8, 2017
Distillery Therapeutics

Endocrine / Metabolic

...March 2, 2017)). TARGET/MARKER/PATHWAY: Anti-Mullerian hormone (AMH) LICENSING STATUS: Patent application filed; exclusively optioned to Provulis LLC...
...Boston, Mass. email: pdonahoe@partners.org CONTACT: David Pépin, same affiliation as above email: dpepin@mgh.harvard.edu Karen Tkach Massachusetts General Hospital Provulis LLC Anti-Mullerian...
BioCentury | Mar 2, 2017
Targets & Mechanisms

Fertile testing ground

...by keeping ovarian follicles quiet during chemotherapy. The scientists behind the work have spun out Provulis LLC...
...a big issue for these patients and patients with other cancers receiving chemotherapy,” said Donahoe. Provulis...
...include genetic or age-related primary ovarian insufficiency, polycystic ovary syndrome (PCOS), IVF and ovarian cancer. Provulis...
Items per page:
1 - 2 of 2
BioCentury | Mar 8, 2017
Distillery Therapeutics

Endocrine / Metabolic

...March 2, 2017)). TARGET/MARKER/PATHWAY: Anti-Mullerian hormone (AMH) LICENSING STATUS: Patent application filed; exclusively optioned to Provulis LLC...
...Boston, Mass. email: pdonahoe@partners.org CONTACT: David Pépin, same affiliation as above email: dpepin@mgh.harvard.edu Karen Tkach Massachusetts General Hospital Provulis LLC Anti-Mullerian...
BioCentury | Mar 2, 2017
Targets & Mechanisms

Fertile testing ground

...by keeping ovarian follicles quiet during chemotherapy. The scientists behind the work have spun out Provulis LLC...
...a big issue for these patients and patients with other cancers receiving chemotherapy,” said Donahoe. Provulis...
...include genetic or age-related primary ovarian insufficiency, polycystic ovary syndrome (PCOS), IVF and ovarian cancer. Provulis...
Items per page:
1 - 2 of 2